28 July 2023 - It is time for the public to recognize and strongly support the authority of the US Centers ...
20 July 2023 - As CADTH continues along the path of strategic transformation, we’re working hard to align the evidence products ...
12 July 2023 - The US Chamber of Commerce on Wednesday asked a federal judge in Ohio to block Medicare’s new ...
13 July 2023 - Conditional approval based on data from Phase 3 PROpel trial. ...
8 July 2023 - The Inflation Reduction Act allows CMS to negotiate prices for a small number of Medicare covered ...
30 June 2023 - Starting 1 July, people with Medicare Part B and Medicare Advantage coverage who get their insulin through ...
30 June 2023 - For the first time in history, Medicare has the ability to directly negotiate the prices of covered ...
22 June 2023 - The US Medicare health plan on Thursday offered details of plans to collect patient data as ...
21 June 2023 - The pharmaceutical industry’s largest lobbying group on Wednesday filed a lawsuit challenging provisions in the Biden ...
21 June 2023 - NICE has published final evidence-based recommendations on the use of pembrolizumab (Keytruda) in combination with lenvatinib ...
21 June 2023 - Teikoku Pharma today announced that the US FDA granted fast track designation for TPU-006 in managing post-operative ...
21 June 2023 - NICE has published final evidence-based recommendations on the use of dapagliflozin propanediol monohydrate for the treatment ...
30 May 2023 - Politicians don't agree on much these days, but one thing seems to bring even Democrats and ...
1 June 2023 - Agency outlines how people with Medicare can get these drugs if FDA grants traditional approval ...
22 May 2023 - Cyltezo (adalimumab-adbm) will be commercially available in the US beginning on 1 July 2023. ...